Kala Pharmaceuticals Stock Price History
| KALA Stock | USD 5.65 0.15 2.73% |
Below is the normalized historical share price chart for Kala Pharmaceuticals extending back to July 20, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kala Pharmaceuticals stands at 5.65, as last reported on the 24th of July, with the highest price reaching 5.65 and the lowest price hitting 5.50 during the day.
If you're considering investing in Kala Stock, it is important to understand the factors that can impact its price. Kala Pharmaceuticals is relatively risky given 3 months investment horizon. Kala Pharmaceuticals has Sharpe Ratio of 0.16, which conveys that the firm had a 0.16 % return per unit of risk over the last 3 months. We were able to break down and interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 1.2% are justified by taking the suggested risk. Use Kala Pharmaceuticals Mean Deviation of 5.28, risk adjusted performance of 0.1303, and Downside Deviation of 5.35 to evaluate company specific risk that cannot be diversified away. At present, Kala Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 5.8 M, whereas Common Stock is forecasted to decline to 5,700. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.10, whereas Price To Sales Ratio is forecasted to decline to 16.28. Kala Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of July 2017 | 200 Day MA 5.8931 | 50 Day MA 4.5233 | Beta (1.89) |
Sharpe Ratio = 0.1634
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | KALA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.34 actual daily | 65 65% of assets are less volatile |
Expected Return
| 1.2 actual daily | 24 76% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Kala Pharmaceuticals is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kala Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 6.2173 | Enterprise Value Ebitda (0.16) | Price Sales 1.157 | Shares Float 3.7 M | Wall Street Target Price 13.5 |
Kala Pharmaceuticals Stock Price History Chart
There are several ways to analyze Kala Stock price data. The simplest method is using a basic Kala candlestick price chart, which shows Kala Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 10, 2025 | 6.9 |
| Lowest Price | May 15, 2025 | 3.22 |
Kala Pharmaceuticals July 24, 2025 Stock Price Synopsis
Various analyses of Kala Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Kala Stock. It can be used to describe the percentage change in the price of Kala Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Kala Stock.| Kala Pharmaceuticals Price Daily Balance Of Power | 1.00 | |
| Kala Pharmaceuticals Price Action Indicator | 0.15 | |
| Kala Pharmaceuticals Price Rate Of Daily Change | 1.03 |
Kala Pharmaceuticals July 24, 2025 Stock Price Analysis
Kala Stock Price History Data
The price series of Kala Pharmaceuticals for the period between Fri, Apr 25, 2025 and Thu, Jul 24, 2025 has a statistical range of 3.95 with a coefficient of variation of 20.93. The daily prices for the period are spread out with arithmetic mean of 4.31. The median price for the last 90 days is 4.09. The company underwent 1:50 stock split on 21st of October 2022.| Open | High | Low | Close | Volume | ||
07/24/2025 | 5.50 | 5.65 | 5.50 | 5.65 | ||
07/23/2025 | 5.42 | 5.96 | 5.35 | 5.65 | 485,349 | |
07/22/2025 | 5.73 | 6.01 | 5.40 | 5.50 | 93,655 | |
07/21/2025 | 5.79 | 5.93 | 5.64 | 5.70 | 73,569 | |
07/18/2025 | 5.88 | 6.20 | 5.61 | 5.74 | 42,955 | |
07/17/2025 | 6.07 | 6.19 | 5.82 | 5.97 | 63,253 | |
07/16/2025 | 5.55 | 6.30 | 5.55 | 5.96 | 123,062 | |
| 07/15/2025 | 5.80 | 5.85 | 5.39 | 5.48 | 80,264 | |
| 07/14/2025 | 6.11 | 6.11 | 5.56 | 5.70 | 95,020 | |
| 07/11/2025 | 6.89 | 6.89 | 5.85 | 5.85 | 154,051 | |
07/10/2025 | 6.75 | 7.00 | 5.98 | 6.90 | 142,975 | |
| 07/09/2025 | 5.15 | 6.34 | 5.15 | 6.30 | 899,296 | |
07/08/2025 | 5.36 | 5.58 | 5.15 | 5.16 | 37,024 | |
| 07/07/2025 | 5.16 | 5.75 | 5.15 | 5.28 | 85,078 | |
07/03/2025 | 5.05 | 5.38 | 5.05 | 5.10 | 54,938 | |
07/02/2025 | 4.84 | 5.18 | 4.76 | 5.05 | 52,728 | |
07/01/2025 | 4.70 | 5.18 | 4.51 | 4.84 | 217,316 | |
06/30/2025 | 4.74 | 4.99 | 4.50 | 4.76 | 39,128 | |
06/27/2025 | 5.41 | 5.90 | 4.36 | 4.62 | 160,692 | |
06/26/2025 | 4.72 | 5.39 | 4.61 | 5.26 | 138,046 | |
06/25/2025 | 4.00 | 4.99 | 4.00 | 4.70 | 208,044 | |
| 06/24/2025 | 3.95 | 4.12 | 3.95 | 4.00 | 79,217 | |
06/23/2025 | 4.01 | 4.15 | 3.82 | 4.02 | 57,200 | |
| 06/20/2025 | 4.18 | 4.25 | 4.01 | 4.04 | 23,275 | |
06/18/2025 | 4.37 | 4.38 | 4.20 | 4.24 | 16,533 | |
06/17/2025 | 4.20 | 4.41 | 4.18 | 4.18 | 25,400 | |
06/16/2025 | 4.30 | 4.40 | 4.10 | 4.34 | 20,507 | |
| 06/13/2025 | 4.33 | 4.54 | 4.25 | 4.30 | 18,085 | |
06/12/2025 | 4.59 | 4.72 | 4.40 | 4.45 | 31,567 | |
06/11/2025 | 4.82 | 4.92 | 4.20 | 4.38 | 62,873 | |
06/10/2025 | 4.10 | 4.77 | 4.01 | 4.74 | 110,871 | |
06/09/2025 | 4.14 | 4.19 | 3.98 | 4.11 | 30,615 | |
| 06/06/2025 | 4.16 | 4.16 | 3.76 | 4.14 | 39,447 | |
06/05/2025 | 4.05 | 4.20 | 3.92 | 4.17 | 37,491 | |
06/04/2025 | 4.25 | 4.40 | 3.81 | 4.12 | 64,101 | |
| 06/03/2025 | 3.65 | 4.35 | 3.60 | 4.09 | 123,566 | |
06/02/2025 | 3.70 | 3.86 | 3.50 | 3.52 | 33,580 | |
| 05/30/2025 | 3.82 | 3.88 | 3.61 | 3.72 | 21,174 | |
05/29/2025 | 3.81 | 3.89 | 3.77 | 3.84 | 28,728 | |
05/28/2025 | 3.96 | 4.16 | 3.67 | 3.80 | 32,013 | |
05/27/2025 | 4.07 | 4.12 | 3.92 | 4.06 | 14,694 | |
05/23/2025 | 4.08 | 4.10 | 3.85 | 4.04 | 12,501 | |
05/22/2025 | 3.91 | 4.13 | 3.77 | 4.09 | 20,316 | |
05/21/2025 | 4.06 | 4.20 | 3.70 | 3.77 | 51,347 | |
05/20/2025 | 3.74 | 4.00 | 3.66 | 3.95 | 49,101 | |
05/19/2025 | 3.60 | 3.74 | 3.55 | 3.64 | 20,709 | |
05/16/2025 | 3.27 | 3.85 | 3.27 | 3.67 | 109,100 | |
05/15/2025 | 3.26 | 3.36 | 3.16 | 3.22 | 37,607 | |
05/14/2025 | 3.38 | 3.55 | 3.25 | 3.27 | 48,650 | |
05/13/2025 | 3.53 | 3.62 | 3.40 | 3.48 | 29,847 | |
05/12/2025 | 3.40 | 3.63 | 3.36 | 3.50 | 33,334 | |
05/09/2025 | 3.38 | 3.70 | 3.34 | 3.42 | 31,933 | |
05/08/2025 | 3.41 | 3.55 | 3.15 | 3.43 | 250,371 | |
05/07/2025 | 3.34 | 3.70 | 3.34 | 3.45 | 184,374 | |
05/06/2025 | 3.74 | 3.74 | 3.22 | 3.45 | 77,003 | |
05/05/2025 | 3.70 | 3.79 | 3.50 | 3.63 | 32,491 | |
05/02/2025 | 3.88 | 3.94 | 3.64 | 3.75 | 38,020 | |
05/01/2025 | 3.84 | 4.01 | 3.70 | 3.72 | 27,482 | |
04/30/2025 | 4.30 | 4.40 | 3.75 | 3.97 | 184,611 | |
04/29/2025 | 3.68 | 5.03 | 3.50 | 4.25 | 598,244 | |
| 04/28/2025 | 3.24 | 3.64 | 3.19 | 3.57 | 57,088 |
About Kala Pharmaceuticals Stock history
Kala Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kala is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kala Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kala Pharmaceuticals stock prices may prove useful in developing a viable investing in Kala Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5.5 M | 5.8 M | |
| Net Loss | -40.3 M | -42.4 M |
Kala Pharmaceuticals Quarterly Net Working Capital |
|
Kala Pharmaceuticals Stock Technical Analysis
Kala Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Kala Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kala Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Kala Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kala to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1303 | |||
| Jensen Alpha | 0.6525 | |||
| Total Risk Alpha | (0.70) | |||
| Sortino Ratio | 0.1461 | |||
| Treynor Ratio | 0.6069 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Kala Stock analysis
When running Kala Pharmaceuticals' price analysis, check to measure Kala Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kala Pharmaceuticals is operating at the current time. Most of Kala Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kala Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kala Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kala Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |